<h1>History of SMPV</h1>

<div>
<div>
2011: Mr. Shuwei Zong and colleagues started ginseng peptide research and development.
</div>
<div>
2012: Mr. Shuwei Zong co-founded Jilin TaiGu (Peptide Valley) Bioengineering Co. (the predecessor of SMPV).
</div>
<div>
2014: Jilin TaiGu built 15,000 square meters (3.7 acres) facility with two automatic production lines with proprietary technology to process natural plants such as ginseng into the form of peptides.
</div>
<div>
2014: Jilin TaiGu started to collaborate with Peking University Health Science Center to conduct 24 ginseng peptide related research projects.
</div>
<div>
2015: Jilin Peptide Bioengineering Co., Ltd. was grated the Innovative Patent "Extraction Method for Ginseng Peptide" (ZL201510622841.0).
</div>
<div>
2017: With strategic investment from Sinopharm Group Co., Ltd, Jilin TaiGu Bioengineering Co. became Guoyao TaiGu (SinoMed Peptide Valley).
</div>
</div>
